Viw Magazine

Men's Weekly

.

Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals

  • Written by Viw Magazine

It is expected to become the world’s first heavyweight iteration of a major item to be launched on the market

HONG KONG SAR - Media OutReach Newswire - 7 October 2024 - AIM Vaccine announced on the evening of October 6 that the company has received notification from the National Institutes for Food and Drug Control on the serum antibody test results of the phase III clinical trial of the iterative serum-free rabies vaccine.

Read more

LifeStyle

The Importance Of Professional Fiberglass Boat Repair For Strength, Safety And Long-Term Performance

Boats made from fiberglass are known for their durability, lightweight structure and smooth perfor...

Why Choosing the Right Cosmetic Clinic Bundoora Matters for Confidence and Care

Personal appearance can influence confidence, comfort, and overall wellbeing. Many people seek tre...

Paint Protection Film Brisbane: The Ultimate Guide to Protecting Your Vehicle

Brisbane's harsh subtropical climate, with its intense UV rays, summer storms, and coastal condition...

How Family Court Lawyers Can Guide You Through High-Conflict Parenting Disputes

High-conflict parenting disputes can be draining, unpredictable and emotionally overwhelming, espe...